2013
DOI: 10.1074/jbc.m113.470302
|View full text |Cite
|
Sign up to set email alerts
|

The NAD+ Synthesis Enzyme Nicotinamide Mononucleotide Adenylyltransferase (NMNAT1) Regulates Ribosomal RNA Transcription

Abstract: Background: NMNAT1 catalyzes the last step in NAD ϩ synthesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
46
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(50 citation statements)
references
References 33 publications
4
46
0
Order By: Relevance
“…The axon protection conferred by NMNAT1 seems to be closely related to mitochondria, which is a critical organelle for the maintenance of redox state (59,60). In addition, NMNAT1 also has other functional implications (50,59,(61)(62)(63)(64)(65)(66)(67)(68)(69)(70)(71)(72)(73)(74)(75)(76)(77)(78).…”
Section: Discussionmentioning
confidence: 99%
“…The axon protection conferred by NMNAT1 seems to be closely related to mitochondria, which is a critical organelle for the maintenance of redox state (59,60). In addition, NMNAT1 also has other functional implications (50,59,(61)(62)(63)(64)(65)(66)(67)(68)(69)(70)(71)(72)(73)(74)(75)(76)(77)(78).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, it is directly involved in multiple DNA repair pathways, and it modulates the transcription of several metabolic genes to mediate cell adaptation to nutrient/energy stress [5,6]. Activation of these enzymes is strictly dependent on the availability of their shared cosubstrate NAD, and, indeed, the same stress conditions have also been shown to stimulate the expression of NAD biosynthetic enzymes, like nicotinamide phosphoribosyltransferase and NMN adenylyltransferase-1 [7][8][9][10][11][12]. In lower eukaryotes, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Current studies indicate that both Maf1 and nicotinamide mononucleotide adenylyltransferase (NMNAT1), a positive effector of eNoSC activity, may function as tumor suppressors. Maf1 expression is diminished in human liver cancers [32, 35] while the NMNAT1 locus frequently undergoes heterozygous deletion in human cancers [60]. The ability of Maf1 to control intracellular lipids further suggests that it may also be dysregulated in metabolic diseases, although studies are necessary to assess this possibility.…”
Section: Resultsmentioning
confidence: 99%